TGFB1 and neoplasm: Through both canonical SMAD-dependent signaling and non-canonical pathways (e.g., ERK and PI3K/AKT), TGF-β enhances tumor cell invasiveness and recruits M2 macrophages to remodel the ECM, establishing a pre-metastatic niche (74, 105, 106).